Skip to Content

NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD)

Contact DCTD

Home | Sitemap | Contact DCTD

Search this site

DCTD Programs

Biometric Research Program

Cancer Diagnosis Program

Cancer Imaging Program

Cancer Therapy Evaluation Program

Developmental Therapeutics Program

Radiation Research Program

Translational Research Program

Office of Cancer Clinical Proteomics Research

Office of Cancer Complementary and Alternative Medicine

Follow DCTD on LinkedIn

Featured Trials

Last Updated: 07/15/2019

Featured Trials

NCI-MATCH: Molecular Analysis for Therapy Choice

ALCHEMIST: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial

Lung-MAP: Lung Cancer Master Protocol

NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors

Adding Targeted Therapy to Treatment for Esophageal Cancer

TAILORx Breast Cancer Trial

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Copanlisib and Nivolumab in Treating Patients With Metastatic Solid Tumors or Lymphoma

Biomarker/ALK Inhibitor Combinations in Treating Patients with Stage IV ALK Positive Non-Squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol)

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors

DCTD Programs

Biometric Research Program

Cancer Diagnosis Program

Cancer Imaging Program

Cancer Therapy Evaluation Program

Developmental Therapeutics Program

Radiation Research Program

Translational Research Program

Office of Cancer Clinical Proteomics Research

Office of Cancer Complementary and Alternative Medicine

Follow DCTD on LinkedIn